Cytek Biosciences

A biotechnology firm that develops and supplies advanced, cost-effective flow cytometry instruments and related services used worldwide by researchers and clinicians. Its compact systems and streamlined workflows enable high-throughput, single-cell analysis for applications such as cancer immunology, leukemia and lymphoma diagnosis, and transplant monitoring. Distinguished by offering high-end capabilities at lower cost, the company accelerates scientific discovery through technical innovation, exceptional customer support, and a commitment to ethical practices and community engagement. Headquartered in Fremont, California, it has been publicly traded on NASDAQ since 2021.